Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of tranexamic acid and dexmedetomidine on surgical bleeding in spinal posterior fusion
IRCT20200910048678N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid and dexmedetomidine (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Amount of bleeding. Started Dec 2021; status: completed.
02
Drugs
tranexamic aciddexmedetomidine
Beyond the preview
Go deeper on IRCT20200910048678N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200910048678N2.